{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:20:32Z","timestamp":1776824432870,"version":"3.51.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/NEU-NMC\/0248\/2012"],"award-info":[{"award-number":["PTDC\/NEU-NMC\/0248\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/72891\/2010"],"award-info":[{"award-number":["SFRH\/BPD\/72891\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/DTP\/04138\/2013"],"award-info":[{"award-number":["UID\/DTP\/04138\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005855","name":"Universidade Nova de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>The mechanisms underlying neurodegeneration in Parkinson\u2019s disease (PD) are still not fully understood. Glycosylation is an important post-translational modification that affects protein function, cell-cell contacts and inflammation and can be modified in pathologic conditions. Although the involvement of aberrant glycosylation has been proposed for PD, the knowledge of the diversity of glycans and their role in PD is still minimal. Sialyl Lewis X (sLeX) is a sialylated and fucosylated tetrasaccharide with essential roles in cell-to-cell recognition processes. Pathological conditions and pro-inflammatory mediators can up-regulate sLeX expression on cell surfaces, which has important consequences in intracellular signalling and immune function. Here, we investigated the expression of this glycan using in vivo and in vitro models of PD. We show the activation of deleterious glycation-related pathways in mouse striatum upon treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxin-based model of PD. Importantly, our results show that MPTP triggers the presentation of more proteins decorated with sLeX in mouse cortex and striatum in a time-dependent manner, as well as increased mRNA expression of its rate-limiting enzyme fucosyltransferase 7. sLeX is expressed in neurons, including dopaminergic neurons, and microglia. Although the underlying mechanism that drives increased sLeX epitopes, the nature of the protein scaffolds and their functional importance in PD remain unknown, our data suggest for the first time that sLeX in the brain may have a role in neuronal signalling and immunomodulation in pathological conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key messages<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>MPTP triggers the presentation of proteins decorated with sLeX in mouse brain.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>MPTP triggers the expression of sLeX rate-limiting enzyme FUT 7 in striatum.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>sLeX is expressed in neurons, including dopaminergic neurons, and microglia.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>sLeX in the brain may have a role in neuronal signalling and immunomodulation.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00109-023-02415-3","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T05:02:05Z","timestamp":1704862925000},"page":"365-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Altered expression of Sialyl Lewis X in experimental models of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"102","author":[{"given":"Maria Jo\u00e3o","family":"Nunes","sequence":"first","affiliation":[]},{"given":"Andreia Neves","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Alexandra I.","family":"Rosa","sequence":"additional","affiliation":[]},{"given":"Paula A.","family":"Videira","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Gama","sequence":"additional","affiliation":[]},{"given":"Elsa","family":"Rodrigues","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5829-8933","authenticated-orcid":false,"given":"Margarida","family":"Castro-Caldas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"2415_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"2415_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnins.2018.00381","volume":"12","author":"PAQ Videira","year":"2018","unstructured":"Videira PAQ, Castro-Caldas M (2018) Linking Glycation and glycosylation with inflammation and mitochondrial dysfunction in Parkinson\u2019s disease. Front Neurosci 12:381. https:\/\/doi.org\/10.3389\/fnins.2018.00381","journal-title":"Front Neurosci"},{"key":"2415_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JPD-130250","volume":"3","author":"GT Kannarkat","year":"2013","unstructured":"Kannarkat GT, Boss JM, Tansey MG (2013) The role of innate and adaptive immunity in Parkinson\u2019s disease. J Parkinsons Dis 3:493\u2013514. https:\/\/doi.org\/10.3233\/JPD-130250","journal-title":"J Parkinsons Dis"},{"key":"2415_CR4","doi-asserted-by":"publisher","first-page":"9139","DOI":"10.1007\/s12035-018-1062-4","volume":"55","author":"AI Rosa","year":"2018","unstructured":"Rosa AI, Duarte-Silva S, Silva-Fernandes A, Nunes MJ, Carvalho AN, Rodrigues E, Gama MJ, Rodrigues CMP, Maciel P, Castro-Caldas M (2018) Tauroursodeoxycholic acid improves motor symptoms in a mouse model of Parkinson\u2019s disease. Mol Neurobiol 55:9139\u20139155. https:\/\/doi.org\/10.1007\/s12035-018-1062-4","journal-title":"Mol Neurobiol"},{"key":"2415_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2019.01.003","volume":"96","author":"MO Mendes","year":"2019","unstructured":"Mendes MO, Rosa AI, Carvalho AN, Nunes MJ, Dionisio P, Rodrigues E, Costa D, Duarte-Silva S, Maciel P, Rodrigues CMP et al (2019) Neurotoxic effects of MPTP on mouse cerebral cortex: modulation of neuroinflammation as a neuroprotective strategy. Mol Cell Neurosci 96:1\u20139. https:\/\/doi.org\/10.1016\/j.mcn.2019.01.003","journal-title":"Mol Cell Neurosci"},{"key":"2415_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2014.05.061","volume":"275","author":"B Linnartz-Gerlach","year":"2014","unstructured":"Linnartz-Gerlach B, Mathews M, Neumann H (2014) Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins. Neurosci 275:113\u2013124. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.05.061","journal-title":"Neurosci"},{"key":"2415_CR7","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1021\/acs.jproteome.9b00504","volume":"18","author":"BG Cho","year":"2019","unstructured":"Cho BG, Veillon L, Mechref Y (2019) N-Glycan profile of cerebrospinal fluids from Alzheimer\u2019s disease patients using liquid chromatography with mass spectrometry. J Proteome Res 18:3770\u20133779. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00504","journal-title":"J Proteome Res"},{"key":"2415_CR8","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1007\/s12035-019-1482-9","volume":"56","author":"J Costa","year":"2019","unstructured":"Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M (2019) Exploring cerebrospinal fluid IgG N-glycosylation as potential biomarker for amyotrophic lateral sclerosis. Mol Neurobiol 56:5729\u20135739. https:\/\/doi.org\/10.1007\/s12035-019-1482-9","journal-title":"Mol Neurobiol"},{"key":"2415_CR9","doi-asserted-by":"publisher","first-page":"1078854","DOI":"10.3389\/fnmol.2022.1078854","volume":"15","author":"JS Schneider","year":"2022","unstructured":"Schneider JS, Singh G (2022) Altered expression of glycobiology-related genes in Parkinson\u2019s disease brain. Front Mol Neurosci 15:1078854. https:\/\/doi.org\/10.3389\/fnmol.2022.1078854","journal-title":"Front Mol Neurosci"},{"key":"2415_CR10","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1021\/acs.jproteome.1c00219","volume":"20","author":"H Wilkinson","year":"2021","unstructured":"Wilkinson H, Thomsson KA, Rebelo AL, Hilliard M, Pandit A, Rudd PM, Karlsson NG, Saldova R (2021) The O-glycome of human nigrostriatal tissue and its alteration in Parkinson\u2019s disease. J Proteome Res 20:3913\u20133924. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00219","journal-title":"J Proteome Res"},{"key":"2415_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10719-020-09912-4","volume":"37","author":"F Jin","year":"2020","unstructured":"Jin F, Wang F (2020) The physiological and pathological roles and applications of Sialyl Lewis X, a common carbohydrate ligand of the three selectins. Glycoconj J 37:277\u2013291. https:\/\/doi.org\/10.1007\/s10719-020-09912-4","journal-title":"Glycoconj J"},{"key":"2415_CR12","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1074\/jbc.RA117.000775","volume":"293","author":"N Mondal","year":"2018","unstructured":"Mondal N, Dykstra B, Lee J, Ashline DJ, Reinhold VN, Rossi DJ, Sackstein R (2018) Distinct human alpha(1,3)-fucosyltransferases drive Lewis-X\/Sialyl Lewis-X assembly in human cells. J Biol Chem 293:7300\u20137314. https:\/\/doi.org\/10.1074\/jbc.RA117.000775","journal-title":"J Biol Chem"},{"key":"2415_CR13","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1111\/j.1742-4658.2006.05437.x","volume":"273","author":"M Sperandio","year":"2006","unstructured":"Sperandio M (2006) Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 273:4377\u20134389. https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05437.x","journal-title":"FEBS J"},{"key":"2415_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2011.05.026","volume":"409","author":"Z Silva","year":"2011","unstructured":"Silva Z, Tong Z, Cabral MG, Martins C, Castro R, Reis C, Trindade H, Konstantopoulos K, Videira PA (2011) Sialyl LewisX-dependent binding of human monocyte-derived dendritic cells to selectins. Biochem Biophys Res Commun 409:459\u2013464. https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.026","journal-title":"Biochem Biophys Res Commun"},{"key":"2415_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/glycob\/cwg048","volume":"13","author":"S Nishihara","year":"2003","unstructured":"Nishihara S, Iwasaki H, Nakajima K, Togayachi A, Ikehara Y, Kudo T, Kushi Y, Furuya A, Shitara K, Narimatsu H (2003) Alpha 1,3-fucosyltransferase IX (Fut9) determines Lewis X expression in brain. Glycobiol 13:445\u2013455. https:\/\/doi.org\/10.1093\/glycob\/cwg048","journal-title":"Glycobiol"},{"key":"2415_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/bs.apcsb.2019.08.008","volume":"119","author":"S Groux-Degroote","year":"2020","unstructured":"Groux-Degroote S, Cavdarli S, Uchimura K, Allain F, Delannoy P (2020) Glycosylation changes in inflammatory diseases. Adv Protein Chem Struct Biol 119:111\u2013156. https:\/\/doi.org\/10.1016\/bs.apcsb.2019.08.008","journal-title":"Adv Protein Chem Struct Biol"},{"key":"2415_CR17","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.bbagen.2018.05.013","volume":"1862","author":"MA Carrascal","year":"2018","unstructured":"Carrascal MA, Silva M, Ferreira JA, Azevedo R, Ferreira D, Silva AMN, Ligeiro D, Santos LL, Sackstein R, Videira PA (2018) A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer. Biochim Biophys Acta 1862:2069\u20132080. https:\/\/doi.org\/10.1016\/j.bbagen.2018.05.013","journal-title":"Biochim Biophys Acta"},{"key":"2415_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2007.03.011","volume":"26","author":"A Hidalgo","year":"2007","unstructured":"Hidalgo A, Peired AJ, Wild M, Vestweber D, Frenette PS (2007) Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 26:477\u2013489. https:\/\/doi.org\/10.1016\/j.immuni.2007.03.011","journal-title":"Immunity"},{"key":"2415_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-019-03188-x","volume":"143","author":"SA Jassam","year":"2019","unstructured":"Jassam SA, Maherally Z, Ashkan K, Pilkington GJ, Fillmore HL (2019) Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood-brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis. J Neurooncol 143:405\u2013415. https:\/\/doi.org\/10.1007\/s11060-019-03188-x","journal-title":"J Neurooncol"},{"key":"2415_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/jnr.490370406","volume":"37","author":"J Satoh","year":"1994","unstructured":"Satoh J, Kim SU (1994) Differential expression of Lewis(x) and Sialyl-Lewis(x) antigens in fetal human neural cells in culture. J Neurosci Res 37:466\u2013474. https:\/\/doi.org\/10.1002\/jnr.490370406","journal-title":"J Neurosci Res"},{"key":"2415_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/glycob\/cwm024","volume":"17","author":"S Parry","year":"2007","unstructured":"Parry S, Ledger V, Tissot B, Haslam SM, Scott J, Morris HR, Dell A (2007) Integrated mass spectrometric strategy for characterizing the glycans from glycosphingolipids and glycoproteins: direct identification of Sialyl Le(x) in mice. Glycobiol 17:646\u2013654. https:\/\/doi.org\/10.1093\/glycob\/cwm024","journal-title":"Glycobiol"},{"key":"2415_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12031-008-9141-z","volume":"38","author":"M Castro-Caldas","year":"2009","unstructured":"Castro-Caldas M, Neves Carvalho A, Peixeiro I, Rodrigues E, Lechner MC, Gama MJ (2009) GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL\/6 mouse midbrain and striatum. Journal of molecular neuroscience\u202f: MN 38:114\u2013127. https:\/\/doi.org\/10.1007\/s12031-008-9141-z","journal-title":"Journal of molecular neuroscience : MN"},{"key":"2415_CR23","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2174\/1871527313666140806144831","volume":"13","author":"JC Tobon-Velasco","year":"2014","unstructured":"Tobon-Velasco JC, Cuevas E, Torres-Ramos MA (2014) Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord: Drug Targets 13:1615\u20131626. https:\/\/doi.org\/10.2174\/1871527313666140806144831","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"2415_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","volume":"317","author":"J Li","year":"2012","unstructured":"Li J, Liu D, Sun L, Lu Y, Zhang Z (2012) Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 317:1\u20135. https:\/\/doi.org\/10.1016\/j.jns.2012.02.018","journal-title":"J Neurol Sci"},{"key":"2415_CR25","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1016\/j.neurobiolaging.2011.12.006","volume":"33","author":"P Teismann","year":"2012","unstructured":"Teismann P, Sathe K, Bierhaus A, Leng L, Martin HL, Bucala R, Weigle B, Nawroth PP, Schulz JB (2012) Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. Neurobiol Aging 33:2478\u20132490. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.12.006","journal-title":"Neurobiol Aging"},{"key":"2415_CR26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3389\/fnins.2018.01035","volume":"12","author":"CA Goncalves","year":"2018","unstructured":"Goncalves CA, Rodrigues L, Bobermin LD, Zanotto C, Vizuete A, Quincozes-Santos A, Souza DO, Leite MC (2018) Glycolysis-derived compounds from astrocytes that modulate synaptic communication. Front Neurosci 12:1035. https:\/\/doi.org\/10.3389\/fnins.2018.01035","journal-title":"Front Neurosci"},{"key":"2415_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2023.151377","volume":"103","author":"MJ Nunes","year":"2023","unstructured":"Nunes MJ, Carvalho AN, Sa-Lemos C, Colaco M, Cervenka I, Ciraci V, Santos SG, Ribeiro MM, Castanheira M, Jannig PR et al (2023) Sustained PGC-1alpha2 or PGC-1alpha3 expression induces astrocyte dysfunction and degeneration. Eur J Cell Biol 103:151377. https:\/\/doi.org\/10.1016\/j.ejcb.2023.151377","journal-title":"Eur J Cell Biol"},{"key":"2415_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2020.101671","volume":"54","author":"K Popiolek-Barczyk","year":"2020","unstructured":"Popiolek-Barczyk K, Ciechanowska A, Ciapala K, Pawlik K, Oggioni M, Mercurio D, De Simoni MG, Mika J (2020) The CCL2\/CCL7\/CCL12\/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Mol Cell Probes 54:101671. https:\/\/doi.org\/10.1016\/j.mcp.2020.101671","journal-title":"Mol Cell Probes"},{"key":"2415_CR29","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1021\/pr901024z","volume":"9","author":"X Zhang","year":"2010","unstructured":"Zhang X, Zhou JY, Chin MH, Schepmoes AA, Petyuk VA, Weitz KK, Petritis BO, Monroe ME, Camp DG, Wood SA et al (2010) Region-specific protein abundance changes in the brain of MPTP-induced Parkinson\u2019s disease mouse model. J Proteome Res 9:1496\u20131509. https:\/\/doi.org\/10.1021\/pr901024z","journal-title":"J Proteome Res"},{"key":"2415_CR30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.biochi.2008.03.002","volume":"90","author":"C Brito","year":"2008","unstructured":"Brito C, Kandzia S, Graca I, Conradt HS, Costa J (2008) Human fucosyltransferase IX: specificity towards N-linked glycoproteins and relevance of the cytoplasmic domain in intra-Golgi localization. Biochimie 90:1279\u20131290. https:\/\/doi.org\/10.1016\/j.biochi.2008.03.002","journal-title":"Biochimie"},{"key":"2415_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.expneurol.2017.05.009","volume":"295","author":"S Moreira","year":"2017","unstructured":"Moreira S, Fonseca I, Nunes MJ, Rosa A, Lemos L, Rodrigues E, Carvalho AN, Outeiro TF, Rodrigues CMP, Gama MJ et al (2017) Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson\u2019s disease. Exp Neurol 295:77\u201387. https:\/\/doi.org\/10.1016\/j.expneurol.2017.05.009","journal-title":"Exp Neurol"},{"key":"2415_CR32","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.bbadis.2017.06.004","volume":"1863","author":"AI Rosa","year":"2017","unstructured":"Rosa AI, Fonseca I, Nunes MJ, Moreira S, Rodrigues E, Carvalho AN, Rodrigues CM, Gama MJ, Castro-Caldas M (2017) Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1863:2171\u20132181. https:\/\/doi.org\/10.1016\/j.bbadis.2017.06.004","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2415_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fnins.2020.00353","volume":"14","author":"X Wang","year":"2020","unstructured":"Wang X, Sun X, Niu M, Zhang X, Wang J, Zhou C, Xie A (2020) RAGE silencing ameliorates neuroinflammation by inhibition of p38-NF-kappaB signaling pathway in mouse model of Parkinson\u2019s disease. Front Neurosci 14:353. https:\/\/doi.org\/10.3389\/fnins.2020.00353","journal-title":"Front Neurosci"},{"key":"2415_CR34","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","volume":"135","author":"K Sathe","year":"2012","unstructured":"Sathe K, Maetzler W, Lang JD, Mounsey RB, Fleckenstein C, Martin HL, Schulte C, Mustafa S, Synofzik M, Vukovic Z et al (2012) S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain\u202f: a journal of neurology 135:3336\u20133347. https:\/\/doi.org\/10.1093\/brain\/aws250","journal-title":"Brain : a journal of neurology"},{"key":"2415_CR35","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00018-020-03673-x","volume":"78","author":"E Angelopoulou","year":"2021","unstructured":"Angelopoulou E, Paudel YN, Piperi C (2021) Emerging role of S100B protein implication in Parkinson\u2019s disease pathogenesis. Cellular and molecular life sciences\u202f: CMLS 78:1445\u20131453. https:\/\/doi.org\/10.1007\/s00018-020-03673-x","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"2415_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2174\/1389203721666200505101734","volume":"21","author":"M Saeed","year":"2020","unstructured":"Saeed M, Kausar MA, Singh R, Siddiqui AJ, Akhter A (2020) The role of glyoxalase in glycation and carbonyl stress induced metabolic disorders. Curr Protein Pept Sci 21:846\u2013859. https:\/\/doi.org\/10.2174\/1389203721666200505101734","journal-title":"Curr Protein Pept Sci"},{"key":"2415_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1042\/BJ20111648","volume":"443","author":"M Xue","year":"2012","unstructured":"Xue M, Rabbani N, Momiji H, Imbasi P, Anwar MM, Kitteringham N, Park BK, Souma T, Moriguchi T, Yamamoto M et al (2012) Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. Biochem J 443:213\u2013222. https:\/\/doi.org\/10.1042\/BJ20111648","journal-title":"Biochem J"},{"key":"2415_CR38","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/1873-3468.12177","volume":"590","author":"AN Carvalho","year":"2016","unstructured":"Carvalho AN, Marques C, Guedes RC, Castro-Caldas M, Rodrigues E, van Horssen J, Gama MJ (2016) S-Glutathionylation of Keap1: a new role for glutathione S-transferase pi in neuronal protection. FEBS Lett 590:1455\u20131466. https:\/\/doi.org\/10.1002\/1873-3468.12177","journal-title":"FEBS Lett"},{"key":"2415_CR39","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/ijms19020580","volume":"19","author":"I Gomes Ferreira","year":"2018","unstructured":"Gomes Ferreira I, Pucci M, Venturi G, Malagolini N, Chiricolo M, Dall\u2019Olio F (2018) Glycosylation as a main regulator of growth and death factor receptors signaling. Int J Mol Sci 19:580. https:\/\/doi.org\/10.3390\/ijms19020580","journal-title":"Int J Mol Sci"},{"key":"2415_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101888","volume":"42","author":"F Khoder-Agha","year":"2021","unstructured":"Khoder-Agha F, Kietzmann T (2021) The glyco-redox interplay: principles and consequences on the role of reactive oxygen species during protein glycosylation. Redox Biol 42:101888. https:\/\/doi.org\/10.1016\/j.redox.2021.101888","journal-title":"Redox Biol"},{"key":"2415_CR41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/bs.irn.2018.08.009","volume":"141","author":"AA Roussakis","year":"2018","unstructured":"Roussakis AA, Piccini P (2018) Molecular imaging of neuroinflammation in idiopathic Parkinson\u2019s Disease. Int Rev Neurobiol 141:347\u2013363. https:\/\/doi.org\/10.1016\/bs.irn.2018.08.009","journal-title":"Int Rev Neurobiol"},{"key":"2415_CR42","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3892\/ijo.2019.4886","volume":"55","author":"IG Ferreira","year":"2019","unstructured":"Ferreira IG, Carrascal M, Mineiro AG, Bugalho A, Borralho P, Silva Z, Dall\u2019olio F, Videira PA (2019) Carcinoembryonic antigen is a Sialyl Lewis x\/a carrier and an Eselectin ligand in nonsmall cell lung cancer. Int J Oncol 55:1033\u20131048. https:\/\/doi.org\/10.3892\/ijo.2019.4886","journal-title":"Int J Oncol"},{"key":"2415_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Miliukhina IV, Bernadotte A (2018) Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-alpha levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol 327:77\u201382. https:\/\/doi.org\/10.1016\/j.cellimm.2018.02.011","journal-title":"Cell Immunol"},{"key":"2415_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/1878-0261.12163","volume":"12","author":"MA Carrascal","year":"2018","unstructured":"Carrascal MA, Silva M, Ramalho JS, Pen C, Martins M, Pascoal C, Amaral C, Serrano I, Oliveira MJ, Sackstein R et al (2018) Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1\/2 and p38 MAPK activation. Mol Oncol 12:579\u2013593. https:\/\/doi.org\/10.1002\/1878-0261.12163","journal-title":"Mol Oncol"},{"key":"2415_CR45","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1073\/pnas.1222263110","volume":"110","author":"NM Okeley","year":"2013","unstructured":"Okeley NM, Alley SC, Anderson ME, Boursalian TE, Burke PJ, Emmerton KM, Jeffrey SC, Klussman K, Law CL, Sussman D et al (2013) Development of orally active inhibitors of protein and cellular fucosylation. Proc Natl Acad Sci USA 110:5404\u20135409. https:\/\/doi.org\/10.1073\/pnas.1222263110","journal-title":"Proc Natl Acad Sci USA"},{"key":"2415_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1515\/BC.2001.026","volume":"382","author":"C Albach","year":"2001","unstructured":"Albach C, Klein RA, Schmitz B (2001) Do rodent and human brains have different N-glycosylation patterns? Biol Chem 382:187\u2013194. https:\/\/doi.org\/10.1515\/BC.2001.026","journal-title":"Biol Chem"},{"key":"2415_CR47","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1093\/bioinformatics\/btz215","volume":"35","author":"G Taherzadeh","year":"2019","unstructured":"Taherzadeh G, Dehzangi A, Golchin M, Zhou Y, Campbell MP (2019) SPRINT-Gly: predicting N- and O-linked glycosylation sites of human and mouse proteins by using sequence and predicted structural properties. Bioinformatics 35:4140\u20134146. https:\/\/doi.org\/10.1093\/bioinformatics\/btz215","journal-title":"Bioinformatics"},{"key":"2415_CR48","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/jimd.12426","volume":"44","author":"A Hullen","year":"2021","unstructured":"Hullen A, Falkenstein K, Weigel C, Huidekoper H, Naumann-Bartsch N, Spenger J, Feichtinger RG, Schaefers J, Frenz S, Kotlarz D et al (2021) Congenital disorders of glycosylation with defective fucosylation. J Inherit Metab Dis 44:1441\u20131452. https:\/\/doi.org\/10.1002\/jimd.12426","journal-title":"J Inherit Metab Dis"},{"key":"2415_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114332","volume":"13","author":"RG Feichtinger","year":"2021","unstructured":"Feichtinger RG, Hullen A, Koller A, Kotzot D, Grote V, Rapp E, Hofbauer P, Brugger K, Thiel C, Mayr JA et al (2021) A spoonful of L-fucose-an efficient therapy for GFUS-CDG, a new glycosylation disorder. EMBO Mol Med 13:e14332. https:\/\/doi.org\/10.15252\/emmm.202114332","journal-title":"EMBO Mol Med"},{"key":"2415_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.735348","volume":"12","author":"JH Park","year":"2021","unstructured":"Park JH, Marquardt T (2021) Treatment options in congenital disorders of glycosylation. Front Genet 12:735348. https:\/\/doi.org\/10.3389\/fgene.2021.735348","journal-title":"Front Genet"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02415-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T07:05:07Z","timestamp":1708412707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02415-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2415"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02415-3","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with Portuguese (Decreto-Lei n.\u00ba 113\/2013) and European regulations (European Union Directive 2010\/63\/EU). The animal study protocol was approved by the Ethics Committee of the Faculty of Pharmacy, University of Lisbon (643\/817, 2013) and by the Portuguese regulatory entity, Dire\u00e7\u00e3o Geral de Alimenta\u00e7\u00e3o e Veterin\u00e1ria (DGAV\u2014License nr 0421\/000\/000\/2013). Animal facilities and the people directly involved in animal experiments were also certified by DGAV.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}